Intracranial hemorrhage is the most feared complication of thrombolytic therapy. This report describes a 42-year-old diabetic woman who presented with an acute myocardial infarction and suffered a subarachnoid hemorrhage after receiving recombinant tissue plasminogen activator. This report discusses this important but very rare complication of thrombolytic therapy.